Search Results

GPCR University CheatSheet! Filter by topics and access exclusive content for premium members.

GPCR Podcast << Back to podcast list Signals, pH, and Discovery : Cracking GPCR Mysteries Signals, pH , and Discovery: Cracking GPCR Mysteries with Dr. Ian’s unique academic journey—from early interests in medicine to his pivot toward pharmacology and GPCR Yamina underscores the therapeutic potential of GPR65, especially in the context of cancer immunotherapy , and how understanding receptor activity in acidic microenvironments could unlock new therapeutic strategies

GPCR Podcast << Back to podcast list Dr. Nicolas Gilles About Dr. Nicolas Gilles "Dr. He is pioneering the investigation of animal toxins acting on GPCRs, the largest therapeutic target class His strongest expertise lies in therapeutic target identification and all the steps from venom manipulations pharmacological properties of these new ligands are deemed exceptional, a lead optimization is realized and its therapeutic GPCR Thanks for listening to this podcast episode This short survey will help us understand your needs

company supporting pharmaceutical, life science, and academic scientists in the development of new therapeutics analysis of drug action and is known for applying binding kinetics to the development of effective therapeutics , particularly GPCR antagonists. of GPCR function to better target receptors. GPCR Member ResearchGate Dr.

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program

Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

Terry Kenakin Get Started Premium Members benefits: - Subscribe and save 25% on every GPCR Course - Early-bird access - Recordings will be available < Back to GPCR courses Watch recording Your Instructor Dr.

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program

GPCR Podcast << Back to podcast list Dr. Rosie Dawaliby About Dr. Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially GPCR I have developed my expertise in the field of pharmacology and biochemistry of GPCR and the crucial role In 2016, I joined a company that specialized in therapeutic candidate discovery targeting GPCR ( Confo Therapeutics ) as a team and project leader for antibody discovery for metabolic and inflammatory diseases

GPCR Podcast << Back to podcast list Dr. Katarina Nemec About Dr. I aim to discover new therapeutic approaches, and druggable molecules or refine canonical drug targets while performing various cell-based experiments to understand the binding, activation, and signaling of therapeutically relevant GPCRs. GPCR Thanks for listening to this podcast episode This short survey will help us understand your needs

GPCR and become an Ecosystem Contributor!

OFFICIAL BOOKLET Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF

GPCR Podcast << Back to podcast list Dr. Nicola J. Smith About Dr. Nicola J. Smith Dr. Smith’s team has made advances in the understanding of how an orphan GPCR exerts its effects both in , named GPCR-CoINPocket. Her career goal is to leverage this expertise to establish a research program that takes orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic targets

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to schedule Inhibition of Relaxin Autocrine Signaling Confers Therapeutic Vulnerability in Ovarian Cancer Several of these targets are being developed for potential new therapeutic strategies in ovarian and GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires 22nd GPCR Retreat Sponsored by

GPCR Podcast << Back to podcast list Dr. Terry Hébert About this episode Dr. Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University Much of his work is based on GPCR signaling in the context to cardiovascular diseases. on the web Terry Hébert | Institute of Health Sciences Education Hébert Lab LinkedIn Hébert Lab The GPCR GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Premium at a special rate! perfect opportunity for labs, research teams, and organizations to collaborate and access exclusive GPCR GPCR Ecosystem.

GPCR Podcast << Back to podcast list Dr. Khaled Abdelrahman About Dr. Khaled Abdelrahman Dr. He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and He received the Canadian Society of Pharmacology and Therapeutics Postdoctoral and Publication awards along with many Young Scientist Awards from the American Society for Pharmacology and Experimental Therapeutics GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Podcast << Back to podcast list When to Walk, When to Run: Lessons from the GPCR Trenches When to Walk, When to Run: Lessons from the GPCR Trenches with Dr. GPCR Podcast features Benjamin Clements , a postdoctoral fellow at the University of Michigan, who brings fresh insight into the therapeutic promise of GPCRs — particularly in the context of opioid pharmacology Clements' work is primarily focused on translational developments of small molecule therapeutics, and

GPCR Podcast << Back to podcast list Dr. Fiona Marshall About this episode Fiona Marshall got fascinated with GPCRs after attending a lecture An expert in GPCR biology, Fiona published the first description of the cloning and structural requirements As a co-founder of Heptares Therapeutics , now called Sosei Heptares , a GPCR-focused drug discovery GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

bases for ligand binding and efficacy to help optimize the design and engineering of more efficacious therapeutics perspective in the pursuit of receptor subtype-specific ligands, a major aspect to achieve safer, on-target therapeutics The Sunahara lab has also been developing protein-based therapeutics using structure-guided design and A notable therapeutic is an enzyme that hydrolyzes cocaine. as a treatment for cocaine abuse, a debilitating disease that would require long-term and sustained therapeutic

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to : RAMP-interacting GPCR Pathways Date & Time Thursday, November 2nd / 4:30 PM Keynote Talk Abstract Coming GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd GPCR Retreat Sponsored by

Retreat 2023 About Program Registration Logo Contest Committee Sponsors GPCR Retreat Program < Back to We hope our research will aid in the development of new therapeutic interventions for the alleviation GPCR Previous Event Next Event Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec Great Lakes GPCR Retreat and Club des Récepteurs à Sept Domaines Transmembranaires du Québec 22nd GPCR Retreat Sponsored by

GPCR Podcast << Back to podcast list Dr. Graeme Milligan About Dr. main research group centers on the function, structure, and regulation of G protein-coupled receptors (GPCRs Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics GPCR Ecosystem Thanks for listening to this podcast episode This short survey will help us understand

GPCR Ecosystem, ensuring transparency and protecting your rights. GPCR, Ecosystem.DrGPCR.com, DrGPCR.com. GPCR conducts business Affiliate Policy Content and Conduct Policy Content Guidelines Terms and Conditions

Full Agenda Adhesion GPCR workshop 2024 CINVESTAV, Mexico City, Mexico October 23-25 Download PDF Program